Due to its high potential for abuse and associated health risks, MDPV has been classified as a controlled substance in many countries. In the United States, it is a Schedule I drug under the Controlled Substances Act, meaning it is illegal to manufacture, distribute, or possess. Similar legal restrictions apply in the European Union and other regions. Despite these regulations, MDPV continues to be synthesized and sold illicitly.
